Greater exposure to retinol (vitamin A) may prevent prostate cancer, although under some conditions it could promote cell growth and de-differentiation. The authors prospectively examined prostate cancer risk and serum retinol levels, measured by using high-performance liquid chromatography, at baseline (n = 29,104) and after 3 years (n = 22,843) in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort. Cox proportional hazards models were used to estimate the relative risk of total (n = 2,041) and aggressive (n = 461) prostate cancer by quintiles of baseline and 3-year serum retinol concentrations and by change in serum retinol levels from baseline to 3 years. Men with higher retinol concentrations at baseline were more likely to develop prostate cancer (quintile 5 vs. quintile 1 hazard ratio = 1.19, 95% confidence interval: 1.03, 1.36; P(trend) = 0.009). The results were similar for aggressive disease. Joint categorization based on baseline and 3-year retinol levels showed that men who were in the highest quintile at both time points had the greatest increased risk (baseline/3-year quintile 5/quintile 5 vs. quintile 1/quintile 1 hazard ratio = 1.31, 95% confidence interval: 1.08, 1.59). In this largest study to date of vitamin A status and subsequent risk of prostate cancer, higher serum retinol was associated with elevated risk, with sustained high exposure conferring the greatest risk. Future studies may clarify the underlying biologic mechanisms of the retinol-prostate cancer association.
Notes
Cites: Cancer Causes Control. 2009 Aug;20(6):877-8619277882
Cites: Cancer. 1999 Nov 1;86(9):1783-9210547552
Cites: Cancer Prev Res (Phila). 2010 Jun;3(6):745-5220484175
Cites: Cancer Causes Control. 2000 Aug;11(7):617-2610977106
Cites: Am J Clin Nutr. 2000 Nov;72(5):1170-811063445
Cites: Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):749-5611440960
Cites: Nutrition. 2001 Oct;17(10):818-2211684387
Cites: Cancer Causes Control. 2002 Aug;13(6):573-8212195647
Cites: Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):887-9210548317
Cites: Acta Oncol. 2002;41(4):381-812234031
Cites: Am J Epidemiol. 2000 Jan 15;151(2):109-1810645812
Cites: Am J Epidemiol. 2003 Feb 15;157(4):335-4412578804